Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines

Stem Cell Research

Volumn 6, Issue 2, 2011, Pages 158-167

  Dick, Emily ^a   Matsa, Elena ^a   Bispham, Jayson ^a   Reza, Mojgan ^b   Guglieri, Michela ^b   Staniforth, Andrew ^c   Watson, Sue ^a   Kumari, Rajendra ^a   Lochmüller, Hanns ^b   Young, Lorraine ^a   Darling, David ^d   Denning, Chris ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LIN28; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL POPULATION; CELL SELECTION; CELL SUSPENSION; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRECIPITATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TIME MANAGEMENT; VIRUS PARTICLE;

ANIMALS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SEPARATION; CELLS, CULTURED; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION;

EID: 79951517541     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.10.002     Document Type: Article

References (37)

1. Ebert A.D., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
2. Lee G., et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009, 461:402-406.
3. Dimos J.T., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
4. Sullivan G.J., et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010, 51:329-335.
5. Guguen-Guillouzo C., Corlu A., Guillouzo A. Stem cell-derived hepatocytes and their use in toxicology. Toxicology 2010, 270:3-9.
6. Yokoo N., et al. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 2009, 387:482-488.
7. Tanaka T., et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem. Biophys. Res. Commun. 2009, 385:497-502.
8. Zwi L., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009, 120:1513-1523.
9. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
10. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
11. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
12. Kaji K., et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
13. Woltjen K., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
14. Zhou W., Freed C.R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27:2667-2674.
15. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
16. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
17. Kim D., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
18. Zhou H., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
19. Chan E.M., et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27:1033-1037.
20. Chilton J.M., Le Doux J.M. Quantitative analysis of retroviral and lentiviral gene transfer to murine embryonic stem cells. J. Biotechnol. 2008, 138:42-51.
21. Chan L., et al. Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells. J. Virol. 2005, 79:13190-13194.
22. Pham L., Ye H., Cosset F.L., Russell S.J., Peng K.W. Concentration of viral vectors by co-precipitation with calcium phosphate. J. Gene Med. 2001, 3:188-194.
23. Kamps C.A., Lin Y.C., Wong P.K. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 1991, 184:687-694.
24. Nesbeth D., et al. Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation. Mol. Ther. 2006, 13:814-822.
25. Park I.H., Lerou P.H., Zhao R., Huo H., Daley G.Q. Generation of human-induced pluripotent stem cells. Nat. Protoc. 2008, 3:1180-1186.
26. Reubinoff B.E., Pera M.F., Vajta G., Trounson A.O. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum. Reprod. 2001, 16:2187-2194.
27. Baup D., et al. Variegation and silencing in a lentiviral-based murine transgenic model. Transgenic Res. 2010, 19:399-414.
28. Smith J.R., Whitney R.G. Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. Science 1980, 207:82-84.
29. Park I.H., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
30. Cowan C.A., et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J. Med. 2004, 350:1353-1356.
31. Xu C., et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 2001, 19:971-974.
32. Burridge P.W., et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 2007, 25:929-938.
33. Priddle H., et al. Bioluminescence imaging of human embryonic stem cells transplanted in vivo in murine and chick models. Cloning Stem Cells 2009, 11:259-267.
34. Braam S.R., et al. Improved genetic manipulation of human embryonic stem cells. Nat. Meth. 2008, 5:389-392.
35. Denning C., et al. Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int. J. Dev. Biol. 2006, 50:27-37.
36. Kim K.P., et al. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res. 2007, 17:1731-1742.
37. Deb-Rinker P., Ly D., Jezierski A., Sikorska M., Walker P.R. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J. Biol. Chem. 2005, 280:6257-6260.